L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model

• Asıl Yazarlar: Abrianna Beever (Yazar), Nala Kachour (Yazar), James Owens (Yazar), Kayvan Sasaninia (Yazar), Afsal Kolloli (Yazar), Ranjeet Kumar (Yazar), Santhamani Ramasamy (Yazar), Christina Sisliyan (Yazar), Wael Khamas (Yazar), Selvakumar Subbian (Yazar), Vishwanath Venketaraman (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Both active tuberculosis (TB) and asymptomatic latent Mycobacterium tuberculosis (M. tb) infection (LTBI) cause significant health burdens to humans worldwide. Individuals with immunocompromising health conditions, such as Type 2 Diabetes Mellitus (T2DM), have a weakened ability to control M. tb inf...